KMT2A and acute myeloid leukemia: In a second patient sample, obtained from the bone marrow aspirate of an elderly patient with MLL-associated AML – including trisomy of chromosome 13 (leading to overrepresentation of the FLT3 gene), quizartinib treatment induced apoptosis in these cells with an IC50 ~3000 nM.